title: Managing chemotherapy-induced emesis.
authors.affiliation: Cross Cancer Institute, Edmonton, Alberta, Canada.
authors.forename: E
authors.initials: E
authors.lastname: Bruera
authors.forename: M
authors.initials: M
authors.lastname: Michaud
authors.forename: J
authors.initials: J
authors.lastname: Partington
authors.forename: C
authors.initials: C
authors.lastname: Brenneis
authors.forename: A H
authors.initials: AH
authors.lastname: Paterson
authors.forename: R N
authors.initials: RN
authors.lastname: MacDonald
mesh_terms: D000970:Antineoplastic Agents / Q000009:adverse effects*; D006801:Humans; D007263:Infusions, Parenteral; D007279:Injections, Subcutaneous; D008787:Metoclopramide / Q000008:administration & dosage / Q000627:therapeutic use*; D014839:Vomiting / Q000139:chemically induced / Q000188:drug therapy*
chemical_list: D000970:Antineoplastic Agents; D008787:Metoclopramide